MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Selegiline

Selected References:

  • Bauer RL, et al. 2017. Use of transdermal selegiline in pregnancy and lactation: a case report. Psychosomatics, 58(4):450-452.
  • Hagell P, et al. 1998. Pregnancy in Parkinson’s disease: a review of the literature and a case report. Mov Disord, 13(1):34-38.
  • Kupsch A, Oertel WH. 1998. Selegiline, pregnancy, and Parkinson’s disease. Mov Disord, 13(1):175-176.
  • Selegiline Drug Labels. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021479s003s004lbl.pdf and https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021336s002lbl.pdf.
  • Shimazu H, et al. 1995. [Study on oral administration of FPF 1100 prior to pregnancy, pregnancy and lactation period in rats.] Yakuri To Chiryo, 23(1):57-70.
  • Whitaker-Azmitia PM, et al. 1994. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology, 11(2):125-132.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.